ticlopidine has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 3 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| White, AJ | 1 |
| den Toom, ML | 1 |
| van Leeuwen, MW | 1 |
| Szatmári, V | 1 |
| Teske, E | 1 |
| Hata, K | 1 |
| Kitada, N | 1 |
| Gomyo, T | 1 |
| Hamanaka, M | 1 |
| Koganei, A | 1 |
| Kan, Z | 1 |
| Kawaguchi, S | 1 |
| Amemiya, T | 1 |
1 trial available for ticlopidine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study.
Topics: Adenosine Diphosphate; Animals; Asymptomatic Diseases; Blood Coagulation; Cardiomyopathy, Hypertroph | 2017 |
2 other studies available for ticlopidine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
End-stage hypertrophic cardiomyopathy in a cat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Atenolol; Benzazepines; C | 2015 |
[A case of hypertrophic obstructive cardiomyopathy with left atrial giant thrombus during anti-platelet therapy].
Topics: Aged; Cardiomyopathy, Hypertrophic; Coronary Disease; Coronary Thrombosis; Echocardiography; Female; | 1989 |